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Abstract
Local health status and health care use may be negatively influenced by low local socio-economic profile, population
decline and population ageing. To support the need for targeted local health care, we explored spatial patterns of type 2
diabetes mellitus (T2DM) drug use at local level and determined its association with local demographic, socio-economic and
access to care variables. We assessed spatial variability in these associations. We estimated the five-year prevalence of T2DM
drug use (2005–2009) in persons aged 45 years and older at four-digit postal code level using the University of Groningen
pharmacy database IADB.nl. Statistics Netherlands supplied data on potential predictor variables. We assessed spatial
clustering, correlations and estimated a multiple linear regression model and a geographically weighted regression (GWR)
model. Prevalence of T2DM medicine use ranged from 2.0% to 25.4%. The regression model included the extent of
population ageing, proportion of social welfare/benefits, proportion of low incomes and proportion of pensioners, all
significant positive predictors of local T2DM drug use. The GWR model demonstrated considerable spatial variability in the
association between T2DM drug use and above predictors and was more accurate. The findings demonstrate the added
value of spatial analysis in predicting health care use at local level.
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Introduction
In the near future, local health care use in European regions is
expected to change as a consequence of demographic processes [1]
as well as socio-economic change [2–4]. Firstly, population ageing
increases the overall use of health care [2]. Secondly, regional
socioeconomic polarization, which is strengthened by selective
migration [3], causes growing regional inequalities in health [5].
Areas with population decline are expected to have a lower
socioeconomic status, an older population and higher health care
use at the population level [6].
On the other hand, the availability of services, amongst which is
health care, is expected to decline in these regions [7]. These
processes may result in a mismatch between supply and demand of
health care [8,9]. In order to deal with this mismatch, the
provision of care needs to be carefully planned. By predicting local
health care needs, research can help policy makers to effectively
allocate health care. Spatial analysis targeting health care needs at
local level can be vital in assessing which areas are at risk of
becoming unhealthy and need more care in the future [10].
In this article, we study type 2 diabetes mellitus (T2DM)
medication use as a case study for health care use at local level.
This chronic disease is a major threat to health and has a high
global burden [11–13]. Furthermore, prevention or early diagnosis
of T2DM is expected to reduce health care costs and increase
quality of life [14].
On the individual level, T2DM is associated with lower social
economic status (SES) [3,15–18]. Since regional population
decline and ageing expectedly cause socioeconomic decline, we
hypothesize that T2DM prevalence correlates negatively with SES
and population growth and positively with population ageing. As
the provision of health care may diminish in declining areas, we
add variables pertaining to access to health care to our analysis.
Furthermore, since SES displays clustering [19], it is likely that
T2DM prevalence will display clustering as well. Finally, we
hypothesize that there will be spatial variations in the relation
between T2DM and the predictors at the local level; hence spatial
analysis will have added value in this type of research.
Our objectives are (1) to find the associations between T2DM
medication use at local level on one hand and socioeconomic and
demographic factors and access to care factors on the other hand;
(2) to develop a model that predicts T2DM medication use
prevalence at local level and (3) to examine spatial variability in
T2DM medication use, possible predictor and the relations
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between them. These objectives will help us to demonstrate the
added value of spatial analysis in local health care use.
Data and Methods
Setting
We used the University of Groningen pharmacy database
IADB.nl (for more information see: http://www.iadb.nl), an
outpatient prescription database with approximately 500,000
persons registered at 55 pharmacies in the Northern Netherlands
[20]. Its study population is representative for the Dutch
population and has been used previously for diabetes research
[21]. Each prescription record contains information on the
prescription date; the quantity dispensed, the dose regimen, the
number of days the prescription is valid, the prescribing physician
and the Anatomical Therapeutic Chemical code (ATC code). Due
to high pharmacy-commitment in the Netherlands, the medication
records are expected to be virtually complete at the individual
level, with the exception of over the counter drugs [22]. In
accordance with the Dutch Law for the Protection of Personal
Data (Wet Bescherming Persoonsgegevens) and the Declaration of
Helsinki, patient data is not allowed to leave the pharmacy,
therefore all patient data was depersonalized before entering the
database. Each patient has a unique anonymous identifier. This
study was approved by the IADB.nl advisory board.
Study Area and Study Population
We analyzed aggregate data from 84 four-digit postal codes
around the city of Groningen. In the IADB.nl each patient can be
linked to a location down to the 4 digit postal code of the home
address. However, because some individuals never receive any
medication and others visit a pharmacy not covered in our
database, the database coverage is not complete. To compensate
this, an estimation of database coverage was made. In this
estimation it was assumed that for municipalities in which all
containing pharmacies are participating, the IADB has coverage
of 100 percent. A population-ratio for each 1-year age and sex
group is calculated for these municipalities. This is done by
dividing the number of persons in the database by the total
inhabitants in these areas (as recorded by Statistics Netherlands).
In areas without complete coverage, the equivalent IADB
coverage is estimated by multiplying the amount of persons in
the database by the population-ratio.
In order to increase the validity of our analysis, we pruned 4-
digit postal code areas by the following requirements: postal code
areas need to have a database coverage .= 100 individuals or
.= 25% of the total inhabitants and have at least two neighboring
areas meeting the same criteria in order to be included in the
research.
Our final study area encompassed 84 adjacent postal code areas
situated around the city of Groningen (see Figure 1) and contained
23 pharmacies connected to IADB.nl. Based on data from
Statistics Netherlands we estimate that this study area was
inhabited by an average of 342,493 individuals during the
research period, of whom 260,688 (76%) were in the IADB
coverage. Amongst those, 98,753 were older than 45 and were
used for calculation of our outcome measure.
Outcome Measure
Our outcome measure was the five-year prevalence of type 2
diabetes mellitus (T2DM) medication use in persons 45 and older
in the period of 2005–2009 by the 4-digit postal code area. Since
the focus of this research is health care use, the definition of
T2DM on the basis of medication use is the most relevant
definition. Patients were considered to have T2DM if they
received a prescription of any oral blood glucose lowering drug(s)
(ATC-code starting with A10B). In the Netherlands these
medications are rarely used off-label [23], therefore this definition
is regarded accurate. To exclude patients with type I diabetes, who
are generally younger and have different socio-demographic
characteristics, we only included oral diabetic medication use in
the outcome. Metformin is sometimes prescribed as fertility-
medication. However in the Netherlands this is not standard
practice and by targeting a population older than 45, we expect
the group of patients using metformin for something other than
diabetes to be low.
Prevalence at 4-digit postal code level was determined by
dividing the total number of individuals older than 45 in 2007
receiving a prescription in the period of 2005–2009 by the average
number of individuals older than 45 in 2007 in the estimated
database coverage between 2005 and 2009.
Predictors
Based on the hypotheses discussed in the introduction, we
included 19 potential predictors, encompassing demographic
variables, socio-economic variables and access to care variables.
Data were obtained from the Statline database, made available by
Statistics Netherlands [24].
To account for sex, the proportion of females in each area was
included; to account for age, variables measuring the proportion of
the population older than 60, respectively 80 and the proportion of
pensioners were included; to account for population decline, a
variable for population growth between 2005–2009 was comput-
ed; to account for the extent of population ageing, a variable for
the difference in the proportion of persons over 65 (the legal
pension age in the Netherlands at that time) between 2005 and
2009 was included. Furthermore, population density was calcu-
lated by dividing the number of inhabitants by the surface area of
each postal code. To account for ethnicity, the proportion of
nonwestern immigrants was included. Several variables pertaining
to socioeconomic status were included: proportion of high income
households; proportion of low income households; average income
per person; average residential property value; proportion of the
labor force that was on any form of social welfare or benefits;
proportion of the households on social welfare and proportion of
the households on disability benefits. Furthermore, we included
some predictors pertaining to access to care: average distance to
nearest GP; average amount of GP practices within three
kilometers; average distance to the nearest hospital; average
amount of hospitals within 20 kilometers. Distances are regarded
as distances by road and averaged across all inhabitants in the
area. An overview of variables and the years to which these apply
is given in Table 1.
Predictors pertaining to SES, access to care and pensioners were
only available at neighborhood level; the definition of neighbor-
hood is: ‘part of a municipality with a homogenous socio-
economic structure or planning (e.g. residential, industrial,
recreational)’ [24]. Data for neighborhoods smaller than 50
persons is not made available publicly by Statistics Netherlands, as
information pertaining to individuals might be distilled from this.
To achieve compatibility with our outcome measure, predictors
had to be estimated at 4-digit postal code level. For this we used
the following procedure: missing cases of neighborhoods ,50
individuals were replaced with district values (for proportions) or
estimated using information of other neighborhoods in the district
as well as district values (for absolute values). Neighborhood values
were recalculated into postal code values using a proportional split
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method [25]. The proportional split method was done in ArcGIS
10.0; a self-written script was used to automate the process.
Statistical Analysis
To explore statistical distributions in the outcome and predictor
variables, we explored the range, mean and standard deviation.
To ascertain the amount of clustering or dispersion of all variables,
spatial autocorrelation was determined through global Moran’s I
in OpenGeoDa 1.0 [26] using a row-standardized spatial weights
matrix based on queen contiguity. The global Moran’s I is an
indicator for spatial autocorrelation and measures whether the
spatial pattern of a variable is clustered, dispersed or random [27].
The Moran’s I value ranges from 21 to 1, where 21 indicates
perfect dispersion and 1 indicates perfect clustering. If the result of
this test is statistically significant, the observed pattern displays
either clustering or dispersion, if the result is not statistically
significant, the spatial pattern is random. [27]. A Local Moran’s I
(LISA) cluster map was created for T2DM medication use
prevalence to determine local clustering. The LISA measures to
what extent each area is surrounded by areas displaying the same
features [27].
In the analytical phase, skewed variables were transformed
exponentially or logarithmically to fit the linear assumption (see
Table 1). We assessed non-spatial and spatial correlation. For our
first research objective, we determined non-spatial correlation
between T2DM prevalence and each of the predictors using
Pearson correlation. To assess colocation between prevalence and
each of the predictors, we calculated the bivariate Moran’s I for
each predictor and prevalence, using OpenGeoDa 1.0. This
measure of spatial correlation shows the association between
prevalence at a given location and the predictor value in
neighboring postal code areas [27].
Our second objective was aimed at finding a model that would
best predict T2DM medication use prevalence at four digit postal
code level, which meant that any combination of predictors was
considered viable, as long as the model was valid. Multiple linear
Figure 1. Five-year prevalence in the study area.
doi:10.1371/journal.pone.0072730.g001
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regression analysis was used to determine the association between
the predictors and the outcome measure. We assessed which
combination of predictors resulted in the best fitted valid model
using the supplementary spatial statistics toolbox for ArcGIS 10.0
(available through ESRI) [28], while testing for normality,
heteroskedasticity, multicollinearity and spatial dependence (using
OpenGeoDa 1.0 for the latter) (see table 2). The residuals of the
model were tested for spatial autocorrelation.
Finally, to address our third objective, we used Geographically
Weighted Regression (GWR) to assess (1) to what extent the
associations we found in the regular multiple linear regression
model varied across the research area and (2) if taking this
variation into account leads to more accurate prediction. The
GWR measures the variation in the B-coefficients across the
research area. A normal linear regression assumes that these
correlations are the same for every area (spatially stationary), but a
GWR assumes that relationships can be stronger in one area than
in another (spatially non-stationary) [29]. The GWR was
estimated using ArcGIS 10.0. To get an indication of the
significance of the predictor coefficients in the GWR, the t-
statistics were calculated by dividing the B-coefficients by their
standard errors. Finally, the residuals of this model were tested for
spatial autocorrelation as well. The GWR was compared to the
multiple linear regression by comparing the sum of the squared
residuals and the adjusted R-square.
Results
Amongst the 98,753 individuals aged 45 and over, the five-year
prevalence of type 2 diabetes mellitus (T2DM) medication use in
the period of 2005–2009 was 13.2 percent. Throughout the
different aggregate postal code areas, T2DM medication use
prevalence ranged from 2.0 percent to 25.4 percent (Figure 1) with
a mean of 11.1 percent and a standard deviation of 5.2 percent.
T2DM medication use displayed a significant spatial pattern
(Moran’s I = 0.13; p = 0.02) with a small amount of clustering. The
LISA revealed two clusters with high prevalence and one cluster
with low prevalence in and around the city of Groningen (see
Figure 1 for locations).
Almost all predictors showed some degree of spatial clustering,
the exception being population growth (Table 1). Predictors
representing access to care demonstrated a high degree of
clustering; these amenities are often located in central or urban
places.
The predictors most strongly correlated with T2DM prevalence
were the proportion of social welfare/benefits (r = 0.55), the
proportions of low and high incomes (r = 0.50 and 20.47,
respectively) and average residential property value (r = 0.45).
Both population growth and the extent of population ageing were
negatively correlated with prevalence. The variables for sex and
age showed no statistically significant correlation.
Many of the predictors that were significantly correlated with
T2DM medication use prevalence, also displayed significant
colocation ( = spatial correlation) with prevalence (Table 1).
However, spatial correlation was lower than non-spatial correla-
tion, indicating that correlation is only partly determined by
location. Although population ageing and population growth were
correlated with T2DM medication use prevalence, there was no
colocation as these variables displayed little spatial autocorrelation.
Some predictor variables displayed colocation with T2DM
medication use prevalence, although non-spatial correlation was
absent. Most of these variables represented access to care.
The final linear prediction model (adjusted R2 = 0.43) included
population ageing, social welfare/benefits, low incomes and
pensioners, which all positively influenced local T2DM prevalence
(Table 2). For population ageing a change in sign occurred
compared to the Pearson correlation, indicating interaction
between predictors. The residuals of this model showed no spatial
autocorrelation.
The GWR model (Figure 2, Table 2) showed that the local
coefficients of most variables varied spatially. The coefficient for
low incomes was fairly stable across the research area and within
the confidence interval of the regular regression model, indicating
a more or less constant relation between T2DM medication use
prevalence and proportion of low incomes across the research
area. Nonetheless the t-values indicate that results in the eastern
part of the research area are less significant. The GWR coefficients
of population ageing, social welfare/benefits and pensioners
exceeded the confidence intervals found in the regular regression.
The proportion of pensioners and population ageing was stronger
associated with T2DM in rural areas than in and around the city
of Groningen, whereas the proportion of social/welfare and
benefits is less important (and significant) in rural areas, but more
in urban areas.
The GWR model demonstrated higher discriminative value
than the multiple regression model (adjusted R2 = 0.45 instead of
0.42), although not for all areas in the model as the local R2
ranged from 0.42 to 0.54. Also, the GWR displayed a better fit
Table 2. Overview of regression results.
Outcome Measure: medication use prevalence over 45
Multiple Linear Regression (Adjusted R2: 0.43) GWR (Adjusted R2: 0.45)
Variable Coefficient Std. Error Probability Range of coefficient
Intercept 210.35*** 3.50 0.004 212.9 – 28.90
Population Ageing 0.48*** 0.15 0.002 0.35–0.93
Social welfare/benefits 0.36*** 0.11 0.002 0.14–0.42
Low incomes 0.24*** 0.07 0.001 0.19–0.25
Pensioners 1.33** 0.52 0.013 0.84–3.34
***significant at 1% confidence level;
**significant at 5% confidence level.
Diagnostics Multiple linear regression: F-statistics: 16.6 (p = 0); Koenker’s studentized Breusch-Pagan Statistic: 3.38 (p = 0.49); Jarque-Bera statistics: 4.17 (p = 0.12);
Multicollinearity condition number: 21.8; Spatial autocorrelation of residuals: Moran’s I: 0.01 (p = 0.74); Langrange multiplier (lag): 0.82 (p = 0.36); Langrange multiplier
(error): 0.08 (p = 0.78).
doi:10.1371/journal.pone.0072730.t002
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(sum of squared residuals = 1064.95 instead of 1196.62). The
residuals of the GWR displayed no spatial autocorrelation.
Discussion
Interpretation of the Findings
The objectives of this study were (1) to find the associations
between T2DM medication use at local level on one hand and
socioeconomic and demographic factors and access to care on the
other hand; (2) to develop a model that predicts T2DM
medication use prevalence at local level and (3) to examine spatial
variability in T2DM, possible predictor and the relations between
them.
With regards to the first objective, we found an association
between SES and type 2 diabetes mellitus (T2DM) medication use
at aggregate level. It seems that although age and sex are relevant
when predicting T2DM at individual level (see for instance [30]),
the differences are less pronounced at an aggregate level. Only the
proportion of pensioners showed a relation with T2DM medica-
tion use at aggregate level.
Demographic change seemed less important as well. As
hypothesized, we observed a negative correlation between
Figure 2. Results of Geographically Weighted Regression.
doi:10.1371/journal.pone.0072730.g002
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population ageing and T2DM at the local level. However, the
relation between population growth/decline and T2DM preva-
lence is weaker than we expected. A possible explanation for this is
that house building is strongly regulated in the Netherlands and
resulting population growth is caused more by planning than by
natural processes at postal code level. A second explanation may
be that our research area does not contain areas designated by
local and national governments as declining regions for which
policy actions are needed to cope with the effects of population
decline [31]. Inclusion of these areas might lead to different
outcomes.
The access to care variables show significant clustering, but little
correlation with T2DM prevalence. An explanation for this could
be the small range of the values of these variables, especially
compared to the national scope [24]. Another explanation could
be that no areas dealing with problems in health care distribution
were included, as our selection was based on people using
pharmacies, which is a form of care.
To meet our second objective, we strove to find the model that
would best predict local T2DM medication use prevalence in our
research area while making use of the available predictors. Our
final model contained two variables relating to SES (proportion of
local incomes and of social welfare and benefits), one to
demographic composition (proportion of pensioners) and one to
demographic change (extent of population ageing). Access to care
variables seemed irrelevant in this multivariate analysis. This
model did not include sex because (a) including this variable would
cause multicollinearity as sex is highly correlated with pensioners
(b) sex showed no relation with T2DM medication use prevalence
in univariate analysis.
To meet our third research objective, variables were explored
spatially and the prediction model was tested for spatial variability.
We hypothesized that T2DM medication use prevalence would be
clustered spatially and that this clustering would be similar in SES
variables. Although many SES variables show a considerable
amount of clustering, clustering of T2DM is limited. There is some
colocation between T2DM prevalence and SES but the non-
spatial correlation is higher.
The low amount of clustering in T2DM prevalence may be
caused by the spatial randomness in population ageing, a predictor
we also found to be associated with prevalence. This randomness
might counterbalance any colocation T2DM prevalence may have
with SES and also decrease the overall clustering of T2DM
prevalence.
When the final prediction model was analyzed with GWR,
spatial variability was found in the associations between T2DM
and these predictors, but also in the significance of these
associations. In general, the GWR model provides a more
accurate prediction than the multiple linear regression model,
thus proving its added value. As the relations in our model vary
across space and as our predictors show specific spatial patterns,
other Dutch areas may yield different models. This advocates
using geographical methods when developing tools for interven-
tion planning.
Our findings are consistent with other studies that found
geographical variation in diabetes, although not always at a local
scale level [32]. The study by Schlundt et al. [33] demonstrates
that mapping and correlating diabetes and possible predictors is
useful, as it helps researchers and policy makers find similarities in
patterns. We found significant spatial clustering for prevalence and
many of the predictors as well, particularly for variables
representing access to care, that could be used to this end.
Furthermore, the studies by Green et al. [34] and Bocquier et al.
[35] demonstrate the use of regression of aggregated area data in
predicting diabetes. Our findings regarding SES and diabetes were
consistent with those in aforementioned studies. However, the fact
that in our model the combination of SES, demographic
composition and demographic change has a higher predictive
power than merely SES variables proves that there is added value
to be found in combining these different concepts when planning
health interventions.
This research was done at a small scale level. Research on
health care use at such a small scale level is particularly suited for
identifying differences in health care use due to, for example,
socioeconomic inequalities across areas [36]. Our findings suggest
that such inequalities may indeed exist in the Netherlands, as the
dimension that seems most important is the socioeconomic status.
There are many ways in which socioeconomic status can relate to
T2DM, often associated with lifestyle. For instance those with a
lower SES may not have a healthy diet or an active lifestyle, as
they can’t afford this or have little knowledge about these matters.
A related factor sometimes mentioned in literature is that those
with a lower SES often have a diminished access to health care
and that his may result in disparities in health across socioeco-
nomic groups [37]. Given that the Netherlands has a universal
health care system, in which every individual has basic insurance
and GP practices are easily accessible [38], this effect should be
minimalized in our study. Although we found very little relations
between physical access to care and T2DM medication use, we
still discovered a negative correlation between T2DM medication
use and SES. This is consistent with studies done on T2DM in
other populations with universal access to health care (see for
instance [39,40]) and it demonstrates that other processes are at
work here, some of which may be targeted by interventions in
certain socioeconomic groups [30,33]. The localized approach we
used in our research could be very helpful in such areas, as it looks
at SES and health care use at a local level. Moreover, the situation
we describe may be different in other areas in the Netherlands,
since our GWR demonstrates that the relation between pensioners
and diabetes varies greatly across space. These variations require
for a more geographical approach in analysis to target areas at
risk.
Strengths and Limitations
This case study is an example on how to predict health care use
at the local level, using spatial analysis. As health care needs to
adapt to population decline, insights from such studies are very
useful in planning future care. SES is something that expresses
itself on this scale level rather than on higher levels, such as
municipalities [41], therefore predictions based on local level data
will be accurate and tailored to the needs of the population.
T2DM is very suitable as a case study as patients are easy to
classify by medication use [16]. Moreover, this illness is amongst
the illnesses that benefit from neighborhood based interventions
[42]; insights from this research could aid the planning of such
interventions.
Although the regular multiple linear regression provides a fairly
accurate prediction model for the research area as a whole, the
GWR is more useful as it illustrates that there is spatial variation in
the associations between outcome measure and predictor vari-
ables. Furthermore in our study the GWR had a higher predictive
power and better fit than the multiple linear regression. This
showcases the added value of spatial analysis.
Another strength of this study is that it makes use of the IADB.nl
database, which is valid and representative for the Dutch
population, and very suitable for epidemiological research [20].
The data obtained from Statistics Netherlands is available
nationwide and for different points in time and is considered to
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be very reliable for scientific research [24]. This makes our
research easily extendable.
In the Netherlands, the average four digit-postal code size in
2007 was approximately 4000 inhabitants [24]. Since our average
postal code size was 4077, our research area is very representative
in this regard. Furthermore, the variability in our outcome
measure T2DM medication use prevalence (2.0% to 25.4%) is
considerable and we deem this to be another strength of this
research. Statistics Netherlands previously measured the unstan-
dardized one-year prevalence of T2DM to be 2.9 percent in 2005–
2008 with a variation of 1.8–4.2 percent between different public
health regions. Since postal codes are much smaller than public
health regions (which generally encompass multiple municipalities
[24]), it’s plausible that our variation was greater and our scale
level should be more accurate in predicting local health care use
[43]. The predictors may not be representative for the Dutch
situation, as data from Statistics Netherlands reveals that our
research area has a lower SES compared to the Dutch average and
that the population lives further from health care than in most
urban areas. A larger range of values within each predictor could
produce different outcomes.
We believe that the possible bias in this study is limited. By
applying strict selection criteria to select a study area, we tried to
limit information bias in our outcome measure, however some of
the samples may still be limited in representativeness as discussed
in the previous paragraph.
Any study using statistics can be influenced by statistical
uncertainty. In our case, not all variables displayed a linear
distribution. We transformed some of the variables logarithmically
or exponentially. However even after transformation, some
distributions were not entirely normally distributed. This is why
we have been mindful of diagnostics for non-normality and we
have no reason to assume that non-normality is a problem in our
regression models.
Secondly, a study using multiple predictor variables has to deal
with correlation between the different variables. In our research
we study many variables relating to SES and also several variables
relating to age and access to care. The fact that some of these
variables are interrelated stands beyond reason. For instance the
proportion of low incomes is highly correlated with the proportion
of high income. In this study we demonstrate that the concepts of
SES and age composition can indeed be used to predict T2DM
medication use. However, that does not mean all variables should
be included when finding the best combination of variables.
During our multivariate analysis we were very careful not to
include variables displaying high multicollinearity. In order to
assess this, we used two tools. Firstly, the exploratory regression
tool in ArcGIS only selects models with low multicollinearity
(variance inflation factor ,7.5). Secondly, we assessed multi-
collinearity in our final model in OpenGeoDa (Multicollinearity
condition number = 21; numbers below 30 are acceptable [27]).
Finally, this study is cross-sectional and consequently only
measures association between the outcome measure and predictors
which are not necessarily causal.
Conclusions and Implications
This study displays the importance of SES and population
ageing in predicting T2DM at the local level. In this research local
regression is preferred over global regression as there is distinct
spatial variability in the associations between T2DM and its
predictors.
Analyzing and predicting medicine use at a local level can be
very useful, as it helps locate areas at risk of becoming unhealthy
[44]. SES characteristics on local level can reflect population
differences in health status and are therefore very useful in
predicting health care use and planning the allocation of care
[45,46]. Moreover, Potential T2DM patients could thus benefit
greatly from lifestyle interventions, as discussed by Schlundt [36].
Our research demonstrate that the local scale level is ideal to target
these patients, therefore policy makers should plan their interven-
tions at the local level. Areas in which intervention is most
profitable may be found by studying local SES, age composition
and population ageing.
Future research can benefit from a localized approach when
explaining or predicting local health care use. In this study we took
spatial analysis a step further than other studies on type 2 diabetes
that used a geographical approach, by examining colocation
besides regular correlation and by estimating a GWR model.
Moreover, we added variables for demographic change. Both of
these aspects have proven to be useful in this study and could be
applied to other epidemiological studies as well. Using spatial
analysis in this type of research is very useful, as it reveals spatial
variation in the relations between health care use and the different
predictors, making the prediction more accurate and tailored to
neighborhoods.
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